NeuroOne Medical Technologies (NASDAQ:NMTC) Releases Quarterly Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) released its quarterly earnings data on Wednesday. The company reported $0.06 EPS for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative return on equity of 407.04% and a negative net margin of 356.76%.

NeuroOne Medical Technologies Trading Down 5.4 %

NMTC stock opened at $1.03 on Wednesday. The stock has a market capitalization of $31.82 million, a PE ratio of -2.36 and a beta of 0.48. NeuroOne Medical Technologies has a 12-month low of $0.55 and a 12-month high of $1.50. The stock’s 50 day simple moving average is $0.94 and its 200 day simple moving average is $0.87.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.